<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-74302</identifier>
<setSpec>0214-1582</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:description xml:lang="en">Lymphangiosarcoma postmastectomy is an uncommonvascular tumor, arising in the area of chronically lymphoedematousextremity, after radical mastectomy and radiotherapyin patients with breast cancer. It shows an incidence of 0,45%among patients that survive more than five years after radicalmastectomy. The etiology of this enigmatic tumor is not yetcompletely understood. There is no standard treatment. Thetreatment options include radical ablative surgery, amputation,radiation therapy and chemotherapy. The prognosis is poor.Survival after diagnosis ranged from 8 to 15 months. We reportthe case of patients with LPM and RT(AU)</dc:description>
<dc:creator>Bayón, A. M</dc:creator>
<dc:creator>Merck, B</dc:creator>
<dc:creator>Vázquez, C</dc:creator>
<dc:creator>Almenar, S</dc:creator>
<dc:creator>Giménez, J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El linfangiosarcoma postmastectomía (LPM) es un tumorvascular muy infrecuente y agresivo, que asienta habitualmenteen brazos portadores de un linfedema de larga evolución,tras una mastectomía radical por cáncer. Su incidencia es del0,45% en pacientes que sobreviven 5 años tras la mastectomíaradical. La etiología de estos tumores es aún completamentedesconocida. En la actualidad no existe un tratamientoestandarizado. Las opciones terapéuticas incluyen la exéresisquirúrgica, amputación de la extremidad afectada, desarticulación,radioterapia y quimioterapia. El pronóstico es malo. Lasupervivencia tras el diagnóstico oscila entre 8 y 15 meses.Presentamos el caso de una paciente con linfangiosarcomapostmastectomía radical y radioterapía(AU)</dc:description>
<dc:source>Rev. senol. patol. mamar. (Ed. impr.);21(1): 34-37, 2008. ilus</dc:source>
<dc:identifier>ibc-74302</dc:identifier>
<dc:title xml:lang="es">Linfangiosarcoma en paciente mastectomizada (síndrome de Stewart-Treves)</dc:title>
<dc:subject>^d8386^s22016</dc:subject>
<dc:subject>^d8386^s22027</dc:subject>
<dc:subject>^d22921^s22066</dc:subject>
<dc:subject>^d8381^s29166</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d22921^s22074</dc:subject>
<dc:subject>^d8580^s22066</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d8580^s22045</dc:subject>
<dc:subject>^d8381^s22009</dc:subject>
<dc:subject>^d8381^s22012</dc:subject>
<dc:subject>^d30193^s22066</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d30193^s22074</dc:subject>
<dc:subject>^d8381^s22032</dc:subject>
<dc:subject>^d8381^s22016</dc:subject>
<dc:subject>^d1968^s22057</dc:subject>
<dc:subject>^d8386^s22012</dc:subject>
<dc:subject>^d1968^s22059</dc:subject>
<dc:type>article</dc:type>
<dc:date>200800</dc:date>
</metadata>
</record>
</ibecs-document>
